Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease

Yong Liu1,2, Donghui Zhang1,2, Dan Yin1,2

  • 1State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan 430062, China.

Insights

This review explores how interleukins impact heart disease by affecting specific heart cells. Understanding these interleukin pathways could lead to more targeted and effective heart disease therapies.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cellular Pathophysiology

Background:

  • Common heart diseases like myocardial infarction and heart failure lack effective therapies due to complex pathogenesis.
  • Cardiomyocytes, fibroblasts, endothelial cells, and immune cells are key players in heart disorders.
  • The specific roles of interleukins and their pathways in these primary heart cells are not well understood.

Purpose of the Study:

  • To review the pathophysiological effects of various interleukins on primary cell types in common heart diseases.
  • To elucidate the complex roles of interleukins in cardiovascular disease.
  • To provide insights for developing more precise and effective heart disease treatments.

Main Methods:

  • Literature review focusing on interleukins and their effects on cardiomyocytes, fibroblasts, endothelial cells, and immune cells.
  • Analysis of pathophysiological pathways involving specific interleukins in heart disease models.
  • Synthesis of current knowledge on interleukin functions in cardiovascular contexts.

Main Results:

  • Interleukins, including the IL-1 family, IL-2, IL-4, IL-6 family, IL-8, IL-10, and IL-17, exhibit diverse effects on different cardiac cell types.
  • Specific interleukin actions can promote or inhibit disease progression depending on the cell type and context.
  • The complex interplay between interleukins and cardiac cells contributes significantly to heart disease pathogenesis.

Conclusions:

  • Targeting specific cell types with tailored interleukin-modulating therapies holds promise for treating heart disease.
  • Further research into interleukin-specific cellular mechanisms is crucial for advancing cardiovascular medicine.
  • A deeper understanding of these pathways can lead to novel therapeutic strategies for myocardial infarction, heart failure, and other cardiac conditions.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
58
Layers of the Heart Wall01:15

Layers of the Heart Wall

The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
2.9K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
22